Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christof Schaefer

Showing results (51-60 of 87) with videos related to

Pageof 9
Sort By:
Seminars in Arthritis and Rheumatism|June 28, 2016
Tocilizumab use in pregnancy: Analysis of a global safety database including data from clinical trials and post-marketing dataMaria Hoeltzenbein, Evelin Beck, Richa Rajwanshi, et al.
Journal of Hypertension|October 5, 2019
Neonatal effects of intrauterine metoprolol/bisoprolol exposure during the second and third trimester: a cohort study with two comparison groupsAngela Kayser, Evelin Beck, Maria Hoeltzenbein, et al.
Antimicrobial Agents and Chemotherapy|May 21, 2014
Observational cohort study of pregnancy outcome after first-trimester exposure to fluoroquinolonesStephanie Padberg, Evelin Wacker, Reinhard Meister, et al.
Infection|July 15, 2019
Pregnancy outcome after first-trimester exposure to fosfomycin for the treatment of urinary tract infection: an observational cohort studyWayan Philipps, Anne-Katrin Fietz, Katja Meixner, et al.
Deutsches Arzteblatt International|May 24, 2011
Cardiovascular diseases in pregnancyVera Regitz-Zagrosek, Ute Seeland, Annette Geibel-Zehender, et al.
Journal of Hypertension|July 10, 2018
Pregnancy outcome after first trimester exposure to bisoprolol: an observational cohort studyMaria Hoeltzenbein, Anne-Katrin Fietz, Angela Kayser, et al.
Vaccine|May 9, 2012
A(H1N1)v2009: a controlled observational prospective cohort study on vaccine safety in pregnancyMarc Oppermann, Juliane Fritzsche, Corinna Weber-Schoendorfer, et al.
BMC Pregnancy and Childbirth|December 20, 2025
Treatment with tumor necrosis factor inhibitors during pregnancy and occurrence of severe infections among exposed infants in GermanyChristina Princk, Nadine Wentzell, Marlies Onken, et al.
Journal of Medical Internet Research|June 25, 2026
Use of the Online Portal "Embryotox" in Routine Health Care: Mixed Methods StudyMarlies Onken, Evelin Beck, Martina Breuning, et al.
Pharmacoepidemiology and Drug Safety|March 5, 2019
Multistate methodology improves risk assessment under time-varying drug intake-a new view on pregnancy outcomes following coumarin exposureTobias Bluhmki, Anne-Katrin Fietz, Regina Stegherr, et al.
Pageof 9

Showing results (51-60 of 87) with videos related to

Sort By:
Pageof 9
Seminars in Arthritis and Rheumatism|June 28, 2016
Tocilizumab use in pregnancy: Analysis of a global safety database including data from clinical trials and post-marketing dataMaria Hoeltzenbein, Evelin Beck, Richa Rajwanshi, et al.
Journal of Hypertension|October 5, 2019
Neonatal effects of intrauterine metoprolol/bisoprolol exposure during the second and third trimester: a cohort study with two comparison groupsAngela Kayser, Evelin Beck, Maria Hoeltzenbein, et al.
Antimicrobial Agents and Chemotherapy|May 21, 2014
Observational cohort study of pregnancy outcome after first-trimester exposure to fluoroquinolonesStephanie Padberg, Evelin Wacker, Reinhard Meister, et al.
Infection|July 15, 2019
Pregnancy outcome after first-trimester exposure to fosfomycin for the treatment of urinary tract infection: an observational cohort studyWayan Philipps, Anne-Katrin Fietz, Katja Meixner, et al.
Deutsches Arzteblatt International|May 24, 2011
Cardiovascular diseases in pregnancyVera Regitz-Zagrosek, Ute Seeland, Annette Geibel-Zehender, et al.
Journal of Hypertension|July 10, 2018
Pregnancy outcome after first trimester exposure to bisoprolol: an observational cohort studyMaria Hoeltzenbein, Anne-Katrin Fietz, Angela Kayser, et al.
Vaccine|May 9, 2012
A(H1N1)v2009: a controlled observational prospective cohort study on vaccine safety in pregnancyMarc Oppermann, Juliane Fritzsche, Corinna Weber-Schoendorfer, et al.
BMC Pregnancy and Childbirth|December 20, 2025
Treatment with tumor necrosis factor inhibitors during pregnancy and occurrence of severe infections among exposed infants in GermanyChristina Princk, Nadine Wentzell, Marlies Onken, et al.
Journal of Medical Internet Research|June 25, 2026
Use of the Online Portal "Embryotox" in Routine Health Care: Mixed Methods StudyMarlies Onken, Evelin Beck, Martina Breuning, et al.
Pharmacoepidemiology and Drug Safety|March 5, 2019
Multistate methodology improves risk assessment under time-varying drug intake-a new view on pregnancy outcomes following coumarin exposureTobias Bluhmki, Anne-Katrin Fietz, Regina Stegherr, et al.
Pageof 9